Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kira Gritsman

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Blood Cancer Discovery|June 1, 2026
KATs in the MYST: A New Therapeutic Vulnerability for SETBP1-Mutated Myeloid MalignanciesMark Soto, Kira Gritsman
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemiaLindsay Gurska, Kira Gritsman
Autophagy|June 8, 2023
Unraveling the Link between Class 1A PI3-Kinase, Autophagy, and MyelodysplasiaKristina Ames, Kira Gritsman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2019
Twist of Fate for Acute Promyelocytic Leukemia: TRIB3-TWIST1 Interaction Promotes ResistanceStephen Z Peeke, Kira Gritsman
Frontiers in Oncology|November 29, 2017
Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem CellsShayda Hemmati, Tamanna Haque, Kira Gritsman
Advances in Experimental Medicine and Biology|July 25, 2019
Signaling Pathways in Leukemic Stem CellsLindsay M Gurska, Kristina Ames, Kira Gritsman
Stem Cells Translational Medicine|November 28, 2024
Targeting chromatin modifying complexes in acute myeloid leukemiaAlexandra Schurer, Shira G Glushakow-Smith, Kira Gritsman
Elife|June 5, 2023
Haploinsufficiency of the essential gene Virginia Folgado-Marco, Kristina Ames, Jacky Chuen, et al.
Blood|December 17, 2009
Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in miceMichael G Kharas, Rachel Okabe, Jared J Ganis, et al.
Blood|July 15, 2015
PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndromeAshley Pandolfi, Robert F Stanley, Yiting Yu, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Blood Cancer Discovery|June 1, 2026
KATs in the MYST: A New Therapeutic Vulnerability for SETBP1-Mutated Myeloid MalignanciesMark Soto, Kira Gritsman
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemiaLindsay Gurska, Kira Gritsman
Autophagy|June 8, 2023
Unraveling the Link between Class 1A PI3-Kinase, Autophagy, and MyelodysplasiaKristina Ames, Kira Gritsman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2019
Twist of Fate for Acute Promyelocytic Leukemia: TRIB3-TWIST1 Interaction Promotes ResistanceStephen Z Peeke, Kira Gritsman
Frontiers in Oncology|November 29, 2017
Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem CellsShayda Hemmati, Tamanna Haque, Kira Gritsman
Advances in Experimental Medicine and Biology|July 25, 2019
Signaling Pathways in Leukemic Stem CellsLindsay M Gurska, Kristina Ames, Kira Gritsman
Stem Cells Translational Medicine|November 28, 2024
Targeting chromatin modifying complexes in acute myeloid leukemiaAlexandra Schurer, Shira G Glushakow-Smith, Kira Gritsman
Elife|June 5, 2023
Haploinsufficiency of the essential gene Virginia Folgado-Marco, Kristina Ames, Jacky Chuen, et al.
Blood|December 17, 2009
Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in miceMichael G Kharas, Rachel Okabe, Jared J Ganis, et al.
Blood|July 15, 2015
PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndromeAshley Pandolfi, Robert F Stanley, Yiting Yu, et al.
Pageof 6